All Infection Prevention & Control articles – Page 40
-
NewsStudy says new drug shows promise in clearing HIV from brain
An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study.
-
NewsResearchers reveal how a bacterium supports healing of chronic diabetic wounds
New research shows that the bacterium, Alcaligenes faecalis (A. faecalis), can facilitate healing of hard-to-treat wounds among people with diabetes.
-
NewsBreakthrough study seeks functional cure for HIV
Researchers in George Mason University’s Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center conducted a breakthrough proof-of-concept study in Nature’s Gene Therapy that found an HIV-like virus particle that could cease the need for lifelong medications. Source: Photo by Evan Cantwell/Office of University Branding/George ...
-
NewsDual action antibiotic could make bacterial resistance nearly impossible
A new antibiotic that works by disrupting two different cellular targets would make it 100 million times more difficult for bacteria to evolve resistance, according to new research
-
NewsNew agent effective against drug-resistant malaria parasites
Scientists have developed a promising new antimalarial agent, DIF-1(+3), which is a derivative of Dictyostelium differentiation-inducing factor-1 (DIF-1).
-
NewsLong-acting injectable cabotegravir for HIV prevention is safe in pregnancy
Long-acting injectable cabotegravir (CAB-LA) was safe and well tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the follow-up phase of a global study.
-
NewsMini lungs make major COVID-19 discoveries possible
Scientists infect miniature lung organoids with the virus responsible for COVID-19, revealing new ways in which the infection spreads and suggesting potential treatments.
-
NewsIsolated viral load test may generate false positive results for people using long-acting PrEP
A single laboratory-based HIV viral load test used by U.S. clinicians who provide people with long-acting, injectable cabotegravir (CAB-LA) HIV pre-exposure prophylaxis (PrEP) did not reliably detect HIV in a multi-country study.
-
NewsWearing a face mask in public spaces cuts risk of common respiratory symptoms, study suggests
Wearing a surgical face mask in public spaces reduces the risk of self-reported respiratory symptoms, finds a trial of adults in Norway.
-
NewsStudy finds how common skin bacterium causes chronic infections after orthopedic surgeries
Scientists investigating chronic bone infections have found that the common skin bacteria Cutibacterium acnes can persist as layers of biofilms for weeks on contaminated titanium or stainless-steel implants.
-
NewsPeptide cocktails could be key to fighting antibiotic resistance
A new study highlights the potential of random antimicrobial peptide mixtures to significantly reduce the risk of resistance evolution compared to single peptides, emphasizing the need for innovative solutions to outpace bacterial resistance and safeguard health.
-
NewsScientists identify possible new transmission factor in hospital-acquired Klebsiella infections
The dangerous multidrug resistant (MDR) pathogen, Klebsiella, thrives under nutrient-deprived polymicrobial community conditions found in hospital environments, a new study reveals.
-
NewsSurgical Infection Society issues new guidelines on the management of intra-abdominal infection
The Surgical Infection Society (SIS) has presented new evidence-based guidelines for the management of intra-abdominal infection (IAI) in the peer-reviewed journal Surgical Infections. “These guidelines are critical in the ongoing work by the Surgical Infection Society to decrease the number of deaths from the most common ...
-
NewsNirmatrelvir/ritonavir antiviral combination shows potential in reducing COVID-19 hospitalizations
A systematic review aimed to summarize published evidence on the efficacy, effectiveness, and safety of nirmatrelvir/ritonavir for COVID-19. The review also intended to assess the robustness of the evidence from randomized controlled trials.
-
NewsNew drug target identified for diseases associated with leukemia-causing virus
Researchers have found a new target for treating diseases associated with human T-cell leukemia virus type 1 (HTLV-1). Blocking kinases, which regulate cellular functions, leads to cell death caused by the degradation of the protein Tax.
-
NewsResearchers expose the rules behind dengue’s invasion strategies
Scientists uncover fundamental rules for how dengue virus infects its mosquito and human hosts, providing hope for identifying therapeutic approaches.
-
NewsStudy sheds light on patterns of Leptospirosis infection
Part of a multi-year project, the study seeks to identify demographic, socioeconomic and environmental factors in a high transmission setting in Brazil.
-
NewsScientists uncover the microbial connection between urinary bladder and vagina
A new study highlights the association between urinary and vaginal pathogenic Escherichia coli in recurrent cystitis in postmenopausal women.
-
NewsScientists investigate effectiveness of non-pharmaceutical interventions against pathogens
Scientists have investigated the success of non-pharmaceutical interventions, analysing almost two million SARS-CoV-2 genomes that occurred in the German population during the years of the pandemic.
-
NewsWastewater could yield thousands of novel viruses, study reveals
Deep metagenomic sequencing of wastewater in Berlin over 17 months shows this technique could help forecast disease outbreaks and monitor the spread of human pathogens. It can also reveal thousands of novel viruses, a new study reveals.